Pfizer (PFE) Tops Q1 EPS by 2c, Revenues Miss; Reaffirmed Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.07 +0.50%
EPS Growth %: -12.6%
Financial Fact:
Provision for taxes on income: 284M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -12.6%
Financial Fact:
Provision for taxes on income: 284M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.15 billion.
Reaffirmed All Components of 2018 Financial Guidance:
- Revenues: $53.5 to $55.5 billion
- Adjusted Diluted EPS: $2.90 to $3.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- On Holding AG (ONON) Stock: Market Doesn't Appreciate Brand's Potential, Says Analyst
- Cintas beats estimates but stock edges lower
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
